X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
hematology (24) 24
humans (20) 20
transplantation (19) 19
oncology (18) 18
cancer (12) 12
acute myeloid-leukemia (10) 10
hematopoietic stem cells (10) 10
leukemia (10) 10
adult (9) 9
female (9) 9
male (8) 8
hematologic malignancies (7) 7
hematology, oncology and palliative medicine (7) 7
outcomes (7) 7
prognosis (7) 7
survival (7) 7
transplantation, homologous (7) 7
treatment outcome (7) 7
abridged index medicus (6) 6
aged (6) 6
analysis (6) 6
bone marrow (6) 6
children (6) 6
immunology (6) 6
middle aged (6) 6
versus-host-disease (6) 6
young adult (6) 6
adolescent (5) 5
adolescents (5) 5
chemotherapy (5) 5
impact (5) 5
mortality (5) 5
young adults (5) 5
acute lymphoblastic leukemia (4) 4
acute lymphoblastic-leukemia (4) 4
adults (4) 4
bone-marrow-transplantation (4) 4
care (4) 4
comorbidity index (4) 4
geriatric assessment (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
medical research (4) 4
medicine, experimental (4) 4
patients (4) 4
quality-of-life (4) 4
therapy (4) 4
united states (4) 4
acute leukemia (3) 3
acute lymphatic leukemia (3) 3
acute lymphocytic leukemia (3) 3
adolescent and young adult (3) 3
advance care planning (3) 3
antineoplastic agents - therapeutic use (3) 3
article (3) 3
c-reactive protein (3) 3
care and treatment (3) 3
diagnosis (3) 3
health aspects (3) 3
hematologic neoplasms - therapy (3) 3
hematopoietic stem cell transplantation (3) 3
hematopoietic stem cell transplantation - mortality (3) 3
hematopoietic-cell transplantation (3) 3
lymphatic leukemia (3) 3
lymphoma (3) 3
lymphomas (3) 3
medical care (3) 3
pediatrics (3) 3
phase-i (3) 3
pilot projects (3) 3
precursor cell lymphoblastic leukemia-lymphoma - therapy (3) 3
prospective studies (3) 3
quality (3) 3
quality management (3) 3
relapse (3) 3
risk (3) 3
risk assessment (3) 3
stem cells (3) 3
stem-cell transplantation (3) 3
surgical procedures, operative (3) 3
total lymphoid irradiation (3) 3
united-states (3) 3
usage (3) 3
acute myelogenous leukemia (2) 2
age factors (2) 2
american society (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antithymocyte globulin (2) 2
biomarkers (2) 2
breast neoplasms - drug therapy (2) 2
breast-cancer (2) 2
cancer care (2) 2
carcinoma (2) 2
cell transplantation (2) 2
clinical medicine (2) 2
clinical trials (2) 2
clinical trials and observations (2) 2
cohort studies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 10/2019, Volume 25, Issue 10, pp. e301 - e302
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S53 - S55
ALL | MRD
Journal Article
Hematology. American Society of Hematology. Education Program, 12/2019, Volume 2019, Issue 1, pp. 17 - 23
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 11/2018, Volume 53, Issue 11, pp. 1416 - 1417
Journal Article
Cancer, ISSN 0008-543X, 03/2013, Volume 119, Issue 6, pp. 1129 - 1131
Despite the widespread use of baseline (18F)fluorodeoxyglucose (FDG)‐positron emission tomography imaging for patients with diffuse large B‐cell lymphoma, its... 
Usage | Lymphomas | Prognosis | Research | Medical imaging equipment
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4778 - 4778
Abstract Background: Leukemia relapse is the leading cause of death for patients who undergo allogeneic hematopoietic cell transplantation (HCT). Relapse... 
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 02/2019, Volume 57, Issue 2, pp. 506 - 506
Journal Article
Cancer, ISSN 0008-543X, 05/2018, Volume 124, Issue 9, pp. 1938 - 1945
BACKGROUND To the authors' knowledge, few population‐based studies to date have evaluated the association between location of care, complications with... 
early mortality | epidemiology | acute myeloid leukemia (AML) | location of care | complications | health services | UNITED-STATES | SURGERY | VOLUME | HOSPITAL CHARACTERISTICS | CARE | IMPACT | ONCOLOGY | TREATMENT PATTERNS | MEDICARE BENEFICIARIES | OUTCOMES | PATIENT SURVIVAL | United States | Humans | Middle Aged | Respiratory Insufficiency - etiology | Male | Cancer Care Facilities - statistics & numerical data | Antineoplastic Agents - administration & dosage | Leukemia, Myeloid, Acute - complications | Renal Insufficiency - etiology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Registries - statistics & numerical data | Adult | Female | Remission Induction - methods | United States Department of Veterans Affairs - statistics & numerical data | Leukemia, Myeloid, Acute - therapy | Respiratory Insufficiency - mortality | California - epidemiology | Treatment Outcome | Renal Insufficiency - mortality | Social Class | Leukemia, Myeloid, Acute - mortality | Heart Arrest - mortality | Survival Analysis | Heart Arrest - etiology | Aged | National Cancer Institute (U.S.) - statistics & numerical data | Health aspects | Adults | Statistical analysis | Complications | Myeloid leukemia | Leukemia | Mortality | Socio-economic aspects | Population studies | Regression analysis | Patients | Socioeconomics | Confidence intervals | Regression models | Hydrologic data | Renal failure | Diagnosis | Heart diseases | Acute myeloid leukemia | Public health | Cancer
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2018, Volume 12, pp. 2293 - 2300
Despite improved rates of remission and cure in newly diagnosed adult acute lymphoblastic leukemia (ALL), the prognosis for patients with relapsed or... 
Inotuzumab ozogamicin | Acute lymphoblastic leukemia | Relapsed/refractory | CD22 | Monoclonal antibody-Drug conjugate | MULTIORGAN FAILURE | CHEMISTRY, MEDICINAL | ANTIBODY-TARGETED CHEMOTHERAPY | VENOOCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | ACUTE LYMPHOCYTIC-LEUKEMIA | inotuzumab ozogamicin | INO-VATE | acute lymphoblastic leukemia | mono-clonal antibody-drug conjugate | relapsed/refractory | NON-HODGKIN-LYMPHOMA | PHARMACOLOGY & PHARMACY | MONOCLONAL-ANTIBODIES | PHASE-I | CLINICAL ACTIVITY | Anti-Bacterial Agents - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Adult | Antineoplastic Agents - therapeutic use | Aminoglycosides - therapeutic use | Antigens | Medical research | Prognosis | Ofatumumab | B cells | Vincristine | Drug approval | Biopharmaceutics | Chemotherapy | Immunotherapy | Medicine, Experimental | Acute lymphocytic leukemia | Cancer | Calicheamicin | Acute lymphatic leukemia | Toxicity | Leukemia | Clinical trials | Cytotoxicity | Lymphatic leukemia | Patients | Survival | CD22 antigen | Antibiotics | Lymphocytes B | Medical prognosis | Monoclonal antibodies | Remission | Blast cells | Pediatrics | Transplants & implants | Cancer therapies | Cell adhesion & migration | Signal transduction | Cell cycle | Bone marrow | Drug dosages | Immunoglobulins | Medicine | Studies | Stem cells | Lymphomas | Adults | Apoptosis | monoclonal antibody drug conjugate
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 6615 - 6615
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2020, Volume 26, Issue 3, pp. S199 - S199
Advance directives (AD) offer the opportunity for goal-concordant care at the end of life (EOL). However, fewer than half of HCT recipients have a documented... 
Journal Article
American Journal of Medical Genetics Part A, ISSN 1552-4825, 06/2019, Volume 179, Issue 6, pp. 1025 - 1029
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 10502 - 10502
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S295 - S296
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 839 - 839
Abstract Introduction: Adolescent and young adult (AYA) cancer survivors are at an increased risk of developing subsequent medical problems, including... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.